Trial Details

Not Recruiting
Basic Information
Clinical ID c4896
Identifier JPRN-UMIN000022104
Trial Title Relevance of fecal calprotectin as a biomarker to predict the outcome of Adalimumab therapy in Ulcerative Colitis patients. - Relevance of fecal calprotectin as a biomarker to predict the outcome of Adalimumab therapy in Ulcerative Colitis patients.
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions Ulcerative Colitis
Interventions NULL
Participant Information
Sponsor Hyogo College of Medicine, Department of Inflammatory Bowel Disease, Division of Internal Medicine
City NULL
Country/Region Japan
Enrollment Criteria
Sex Requirement ALL
Age Requirement NULL
Study Design
Study Type Observational
Phase NULL
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL